ONE AND DONE Trademark

Trademark Overview

On Tuesday, September 17, 2024, a trademark application was filed for ONE AND DONE with the United States Patent and Trademark Office. The USPTO has given the ONE AND DONE trademark a serial number of 98977321. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Tuesday, December 23, 2025. This trademark is owned by Adverum Biotechnologies, Inc.. The ONE AND DONE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Gene therapy research; Research, development, and testing of pharmaceutical preparations for gene therapy; Research, development, and testing of pharmaceutical preparations for gene therapy for use in the treatment of ocular diseases
one and done

General Information

Serial Number98977321
Word MarkONE AND DONE
Filing DateTuesday, September 17, 2024
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateTuesday, December 23, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 29, 2025

Trademark Statements

Goods and ServicesGene therapy research; Research, development, and testing of pharmaceutical preparations for gene therapy; Research, development, and testing of pharmaceutical preparations for gene therapy for use in the treatment of ocular diseases

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 17, 2024
Primary Code042
First Use Anywhere DateMonday, July 21, 2025
First Use In Commerce DateMonday, July 21, 2025

Trademark Owner History

Party NameAdverum Biotechnologies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94063
Party NameAdverum Biotechnologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94063

Trademark Events

Event DateEvent Description
Tuesday, September 17, 2024NEW APPLICATION ENTERED
Tuesday, September 17, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 24, 2024TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, September 24, 2024TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Monday, March 17, 2025ASSIGNED TO EXAMINER
Tuesday, September 24, 2024PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, March 17, 2025NON-FINAL ACTION WRITTEN
Monday, March 17, 2025NON-FINAL ACTION E-MAILED
Monday, March 17, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 19, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 19, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 19, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 1, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 23, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 29, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 29, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 24, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, July 25, 2025TEAS REQUEST TO DIVIDE RECEIVED
Friday, July 25, 2025TEAS STATEMENT OF USE RECEIVED
Saturday, December 20, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 25, 2025DIVISIONAL REQUEST RECEIVED
Tuesday, December 23, 2025DIVISIONAL PROCESSING COMPLETE
Friday, July 25, 2025USE AMENDMENT FILED
Tuesday, December 23, 2025STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 23, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, December 23, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

done gene research therapy preparations pharmaceutical testing development diseases treatment ocular